Louis Griffel

1.7k total citations
38 papers, 1.0k citations indexed

About

Louis Griffel is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, Louis Griffel has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Hepatology and 10 papers in Genetics. Recurrent topics in Louis Griffel's work include Hepatitis C virus research (10 papers), Hemoglobinopathies and Related Disorders (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). Louis Griffel is often cited by papers focused on Hepatitis C virus research (10 papers), Hemoglobinopathies and Related Disorders (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). Louis Griffel collaborates with scholars based in United States, France and Germany. Louis Griffel's co-authors include Kiron M. Das, Clifford A. Brass, John B. Porter, Paul Y. Kwo, Ira M. Jacobson, Maria Domenica Cappellini, Bradley Freilich, Robert S. Brown, Steven L. Flamm and Pabak Mukhopadhyay and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Louis Griffel

37 papers receiving 972 citations

Peers

Countries citing papers authored by Louis Griffel

Since Specialization

Citations

This map shows the geographic impact of Louis Griffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis Griffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis Griffel more than expected).

Fields of papers citing papers by Louis Griffel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louis Griffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis Griffel. The network helps show where Louis Griffel may publish in the future.

Co-authorship network of co-authors of Louis Griffel

This figure shows the co-authorship network connecting the top 25 collaborators of Louis Griffel. A scholar is included among the top collaborators of Louis Griffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louis Griffel. Louis Griffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glucose abnormalities in Asian patients with chronic hepatitis C 2015 ·Drug Design Development and Therapy ·(unknown), R. Orsenigo, Junyi Wang, Louis Griffel, Clifford A. Brass	4
2	Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials) 2014 ·Drug Safety ·Gerd A. Kullak‐Ublick, Michael Merz, Louis Griffel, Neil Kaplowitz, Paul B. Watkins	25
3	Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study 2012 ·Journal of Hepatology ·Thierry Poynard, Jordi Bruix, Eugene R. Schiff, M. Diago, Thomas Berg, Ricardo Moreno‐Otero, André Castro Lyra, F.J. Carrilho, Louis Griffel, Navdeep Boparai, Ruiyun Jiang, Margaret Burroughs, Clifford A. Brass, Janice K. Albrecht	6
4	Long‐term safety and efficacy of deferasirox (Exjade^®) for up to 5 years in transfusional iron‐overloaded patients with sickle cell disease 2011 ·British Journal of Haematology ·Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, Renée V. Gardner, (unknown), Matthew M. Heeney, Baba Inusa, Abdullah Kutlar, Peter A. Lane, Liesl Mathias, John B. Porter, Cameron K. Tebbi, Felicia Wilson, Louis Griffel, Wei Deng, Vanessa Giannone, Thomas D. Coates	58
5	Improvement in Liver Pathology of Patients With β-Thalassemia Treated With Deferasirox for at Least 3 Years 2011 ·Gastroenterology ·Yves Deugnier, Bruno Turlin, Martine Ropert, Maria Domenica Cappellini, John B. Porter, Vanessa Giannone, Yiyun Zhang, Louis Griffel, Pierre Brissot	65
6	Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C 2011 ·Gastroenterology ·Jordi Bruix, Thierry Poynard, Massimo Colombo, Eugene R. Schiff, Kelly W. Burak, E. Jenny Heathcote, Thomas Berg, (unknown), (unknown), R. Kim Guenther, Claus Niederau, Rubén Terg, Pierre Bédossa, Navdeep Boparai, Louis Griffel, Margaret Burroughs, Clifford A. Brass, Janice K. Albrecht	74
7	A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE -Related Hereditary Hemochromatosis 2010 ·Hepatology ·Pradyumna D. Phatak, Pierre Brissot, (unknown), Paul C. Adams, Herbert L. Bonkovsky, John Gross, Peter Malfertheiner, Gordon D. McLaren, Claus Niederau, Alberto Piperno, Lawrie W. Powell, Mark W. Russo, (unknown), Wolfgang Stremmel, Louis Griffel, (unknown), Yiyun Zhang, Antonello Pietrangelo	87
8	Long-Term Safety and Efficacy of Deferasirox (Exjade®) In Transfused Patients with Sickle Cell Disease Treated for up to 5 Years 2010 ·Blood ·Elliott Vichinsky, Françoise Bernaudin, Gian Luca Forni, Renée V. Gardner, (unknown), Matthew M. Heeney, Baba Inusa, Abdullah Kutlar, Peter A. Lane, Liesl Mathias, John B. Porter, Cameron K. Tebbi, Felicia Wilson, Louis Griffel, Wei Deng, Vanessa Giannone, Thomas D. Coates	2
9	Deferasirox Improves Liver Pathology In β-Thalassemia Patients with Transfusional Iron Overload 2010 ·Blood ·Yves Deugnier, Bruno Turlin, Victor Dong, Vanessa Giannone, Yiyun Zhang, Louis Griffel, Pierre Brissot	3
10	Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years. 2009 ·Blood ·Maria Domenica Cappellini, Silverio Perrotta, Leyla Ağaoğlu, Yeşim Aydınok, Marcello Capra, Duran Canatan, Guillermo Drelichman, Yurdanur Kılınç, Carmelo Magnano, John B. Porter, Antonio Piga, Louis Griffel, (unknown), (unknown), Antonis Kattamis	4
11	988 SUSTAINED VIRAL RESPONSE (SVR) IS DEPENDENT ON BASELINE CHARACTERISTICS IN THE RETREATMENT OF PREVIOUS ALFA INTERFERON/RIBAVIRIN (I/R) NONRESPONDERS (NR): FINAL RESULTS FROM THE EPIC3 PROGRAM 2008 ·Journal of Hepatology ·Thierry Poynard, E. Schiff, Rubén Terg, (unknown), Steven L. Flamm, Warren N. Schmidt, Thomas Berg, (unknown), Jenny Heathcote, M. Diago, Thomas J. McGarrity, Pierre Bédossa, Weiping Deng, Pabak Mukhopadhyay, Louis Griffel, Margaret Burroughs, Clifford A. Brass, (unknown)	15
12	Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1 2007 ·Hepatology ·Ira M. Jacobson, Robert S. Brown, Jonathan McCone, Martin Black, (unknown), (unknown), (unknown), (unknown), Paul Y. Kwo, Louis R. Lambiase, Greg Galler, Víctor Araya, Bradley Freilich, Joann Harvey, Louis Griffel, Clifford A. Brass	55
13	Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients 2007 ·Hepatology ·Ira M. Jacobson, Robert S. Brown, Bradley Freilich, Nezam H. Afdhal, Paul Y. Kwo, J. Santoro, Scott Becker, Adil E. Wakil, David Pound, Eliot Godofsky, Robert P. Strauss, David Bernstein, Steven L. Flamm, Mary Pat Pauly, Pabak Mukhopadhyay, Louis Griffel, Clifford A. Brass	221
14	Prevalence of Mabdas-1 Positivity in Biopsy Specimens From the Esophagogastric Junction 2002 ·The American Journal of Gastroenterology ·(unknown), Cornelis A. Seldenrijk, Kiron M. Das, Robin Timmer, Ronald Breumelhof, A. J. P. M. Smout, Peter S. Amenta, Louis Griffel	15
15	The 10-year experience with purinethol (6MP) at the Crohn's and colitis center of New Jersey 2001 ·Gastroenterology ·(unknown), (unknown), Louis Griffel, Kiron M. Das	2
16	Adjustment of DCAD may improve performance. 2000 ·Wilfrido Miguel Contreras‐Sánchez, (unknown), Louis Griffel	1
17	Use of a Novel Monoclonal Antibody in Diagnosis of Barrett's Esophagus 2000 ·Digestive Diseases and Sciences ·Louis Griffel, Peter S. Amenta, Kiron M. Das	33
18	Cyclosporine Therapy in Inflammatory Bowel Disease 1999 ·Journal of Clinical Gastroenterology ·Suryakanth Gurudu, Louis Griffel, (unknown), Kiron M. Das	45
19	THE SMOKE IS BEGINNING TO CLEAR 1996 ·Inflammatory Bowel Diseases ·Louis Griffel, Kiron M. Das	1
20	Pharmacokinetic Profile of Nifedipine GITS in Hypertensive Patients with Chronic Renal Impairment 1994 ·Drugs ·Rebekka K. Schneider, (unknown), Louis Griffel, Rainer Kobelt, E. Brendel, Adrian Iaina	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact